Company Overview
- Website
- stelexis.com
- Employees
- 10
- Industry
- BioTech/Drugs
- SIC Code
-
8731 - Commercial Physical and Biological Research
Financials & Stats
Revenue
$3B
Recent News & Media
Older Age and Neutrophil-to-Lymphocyte Ratio (NLR) Are Predictors of Illness Severity and COVID-Related Mortality in a Multiethnic Urban Cohort of Hematologic Neoplasms Patients: An Updated Analysis
- Nov 4, 2024
- pmc.ncbi.nlm.nih.gov
Venetoclax Combined with “7+3” Induction Chemotherapy Induces High Rates of MRD-Negative Remission in Newly Diagnosed AML Patients Fit for Intensive Chemotherapy Irrespective of Age
- Nov 29, 2023
- sciencedirect.com
GDF11/SMAD Regulated Splicing of GATA1 Is Associated with Response to Luspatercept in Lower-Risk Myelodysplastic Syndromes (LR-MDS)
- Nov 2, 2023
- sciencedirect.com
Novel Clinically Useful Inhibitor of Mediator Complex, RVU120, Relives Differentiation Block in MDS/AML
- Nov 2, 2023
- sciencedirect.com
Transcription Factor Redistributors Pharmacologically Actuate Non-Canonical Gene Networks to Drive AML Differentiation
- Nov 2, 2023
- sciencedirect.com
The Dual Inflammasome/Myddosome Inhibitor HT-6184 Restores Erythropoiesis in MDS/AML
- Nov 2, 2023
- sciencedirect.com
Who is Stelexis Therapeutics
Stelexis Therapeutics is a privately held company based in New York, New York. Founded in 2017, the company employs 10 people and generates an annual revenue of $2.5 million. Stelexis Therapeutics focuses on the discovery and development of novel cancer therapeutics. Their proprietary platform identifies, isolates, and studies stem and progenitor cells that contribute to tumor formation. This platform serves as a target identification engine and drug discovery tool, aiming to address unmet needs in various cancer indications. The company's mission is to transform the cancer therapeutics paradigm and patient care. Their research focuses on understanding the role of early-stage cancer cells in tumor development and utilizing this knowledge to develop innovative treatments. For more information, visit stelexis.com.
Company Leadership
Stelexis Therapeutics Industry Tags
Companies Similar to Stelexis Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to Stelexis Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | 2 | Cambridge, MA | 2005 | |
| 3M | 7 | New York, NY | 2008 | |
| 3M | 3 | New York, NY | ||
| 3M | 2 | Knoxville, TN | 2004 | |
| 3M | 35 | Austin, TX |